Loading...

Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

Australian health care firms eye Asia for growth

Image

11-Sep-15 Australia’s third-largest for-profit hospital operator, Healthe Care, and cardiac testing firm Cardioscan, say that a tough operating environment in Australia means successful operators could expand more profitably overseas. Cardioscan recently introduced its myPatch Holter wireless heart monitor to Hong Kong. Healthe Care, which is set to be put up for sale, says it could work well with a Chinese owner. [image: The Australian]

Read More

Hamstrung by red tape, hospital operators buy their way into India

Image

10-Sep-15 Parkway Pantai, a unit of the world's second largest healthcare group by market value, IHH Healthcare Bhd, intends to use acquisitions to expand in India, where the private hospitals market is estimated to be worth USD55 billion a year, but companies must obtain as many as 70 clearances from federal and local authorities to launch a new facility. [image: Reuters / Shailesh Andrade]

Read More

Shenzhen encourages new TCM hospitals

Image

10-Sep-15 Shenzhen aims to establish five to eight new Traditional Chinese Medicine (TCM) hospitals by 2020. The clinics will get the same preferential policies regarding drug pricing and hiring employees as other health care providers under a program that health authorities hope will bring quality hospitals and doctors to the city. [image: 39Clinic]

Read More

Taiwan well-poised for healthcare in IoT: Google

Image

10-Sep-15 Taiwan is well-poised to develop web-based smart healthcare services in the long term thanks to its strong presence in the global hardware supply chain, Google Taiwan says. A strength in Taiwan's IoT drive is its excellent medical and health insurance systems, which have done the groundwork for Taiwan to move into smart medical services that require integration with hardware. [image: Wang Ying-hao]

Read More

Patients wait up to 24 months for new drugs to be approved in Hong Kong

Image

31-Aug-15 Patients in Hong Kong wait far longer to gain access to innovative medicine than in many other locations because regulations are based on old, rigid protocols. It takes around 18 to 24 months for the authorities to recognise a new drug, while the same medicine can be approved in just 60 days in Singapore. [image: Henry Wong]

Read More
Share

 


0111 Banner square pre launch 250x250